Paul Knight

Stock Analyst at Keybanc

(3.37)
# 1,037
Out of 4,333 analysts
121
Total ratings
46.3%
Success rate
3.24%
Average return

34 Stocks

Repligen
Feb 15, 2024
Maintains: Overweight
Price Target: $210$220
Current: $196.52
Upside: +11.95%
West Pharmaceutical Services
Feb 13, 2024
Maintains: Overweight
Price Target: $440$470
Current: $367.44
Upside: +27.91%
Revvity
Feb 2, 2024
Maintains: Overweight
Price Target: $110$126
Current: $104.44
Upside: +20.64%
Danaher
Feb 1, 2024
Maintains: Overweight
Price Target: $260$290
Current: $253.84
Upside: +14.25%
Avid Bioservices
Dec 8, 2023
Maintains: Overweight
Price Target: $20$14
Current: $7.74
Upside: +80.88%
Bio-Techne
Nov 1, 2023
Maintains: Overweight
Price Target: $115$80
Current: $71.62
Upside: +11.70%
Thermo Fisher
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $564.71
Upside: -
Stevanato Group
Aug 30, 2023
Maintains: Overweight
Price Target: $35$37
Current: $32.17
Upside: +15.01%
Telesis Bio
Aug 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $0.78
Upside: -
Maravai LifeSciences Holdings
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $8.36
Upside: -
Castle Biosciences
Aug 4, 2023
Maintains: Overweight
Price Target: $37$25
Current: $23.87
Upside: +4.76%
Cryoport
Jul 17, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $15.82
Upside: -
Alpha Teknova
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $3.45
Upside: -
Standard BioTools
Jul 12, 2023
Initiates: Overweight
Price Target: $4
Current: $2.45
Upside: +63.27%
Agilent Technologies
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $132.03
Upside: -
Azenta
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $63.37
Upside: -
Harvard Bioscience
Apr 26, 2023
Maintains: Overweight
Price Target: $5$7
Current: $4.41
Upside: +58.73%
Catalent
Dec 19, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $58.77
Upside: -
Avantor
Sep 15, 2022
Maintains: Overweight
Price Target: $51$40
Current: $24.35
Upside: +64.27%
Exagen
May 13, 2022
Maintains: Overweight
Price Target: $20$17
Current: $2.05
Upside: +729.27%
BioLife Solutions
May 10, 2022
Maintains: Overweight
Price Target: $60$30
Current: $17.50
Upside: +71.43%
Charles River Laboratories International
May 5, 2022
Maintains: Overweight
Price Target: $390$300
Current: $247.71
Upside: +21.11%
IQVIA Holdings
Apr 28, 2022
Maintains: Overweight
Price Target: $290$250
Current: $247.26
Upside: +1.11%
OncoCyte
Mar 14, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $3.07
Upside: -
Teleflex
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $237.75
Upside: -
ICU Medical
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $103.59
Upside: -
The Cooper Companies
Jan 8, 2021
Maintains: Overweight
Price Target: $92$99
Current: $96.75
Upside: +2.33%
Avanos Medical
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $19.69
Upside: -
Waters
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $331.25
Upside: -
Veracyte
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $22.18
Upside: -
Scientific Industries
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $1.95
Upside: -
Mesa Laboratories
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $104.74
Upside: -
Interpace Biosciences
Apr 15, 2020
Initiates: Buy
Price Target: n/a
Current: $1.09
Upside: -
Illumina
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $133.00
Upside: -